Log In
Print
BCIQ
Print
Print this Print this
 

CMX157

  Manage Alerts
Collapse Summary General Information
Company Chimerix Inc.
DescriptionOral lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the antiviral agent tenofovir diphosphate
Molecular Target Viral polymerase
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat tenofovir-resistant HIV
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today